(1 - 14 von 14
)
SEC sues CellCyte and its executives
seattletimes.com
[Seattle Times] - CellCyte Genetics of Bothell and top executives Gary Reys and Ronald Berninger were sued Tuesday by the Securities and Exchange Commission, which accuses
SEC sues CellCyte and its executives | The Seattle Times
www.seattletimes.com
CellCyte Genetics of Bothell and top executives Gary Reys and Ronald Berninger were sued Tuesday by the Securities and Exchange Commission, which accuses them...
CellCyte Genetics Corp. ernennt Jay H. Traverse zum klinischen...
www.ots.at
"Wir freuen uns, Dr. Traverse als Mitglied in unserem wissenschaftlichen Beirat begrüßen zu dürfen", sagte Dr. W. Ronald Berninger, ...
CellCyte Genetics Corp. ernennt Jay H. Traverse zum klinischen...
www.finanznachrichten.de
ots.CorporateNews übermittelt durch euro adhoc mit dem Ziel einer europaweiten...
SEC Charges Company With Misleading "Stem Cell" Therapy Promotion
www.dotmed.com
False research and FDA approval claims led to stock rise, SEC says.
Trauerfälle, Todesanzeigen, Traueranzeigen, Totentafel und Ratgeber |...
trauer.main-echo.de
Das Main-Echo Trauerportal. Alle Traueranzeigen und Memoriamanzeigen, sowie eine aktuelle Titentafel.
Sie finden daneben anschauliche Informationen zu...
schaftlichen Beirat
www.finanznachrichten.de
ots.CorporateNews: CellCyte Genetics Corp. ernennt Jay H. Traverse zum klinischen Facharzt im wissenschaftlichen Beirat...
CellCyte Genetics "strong buy" (FIRSTCLASS INVESTOR) | Analysen |...
www.aktiencheck.de
CellCyte Genetics
CellCyte Issued Patent for Stem Cell Delivery Technology
www.genengnews.com
... of damaged tissue and thereby markedly increase opportunities for healing and restoring organ function,” notes Ronald Berninger, CSO.
Mukilteo Beacon October 12, 2011: Page 16
mkb.stparchive.com
Mukilteo Beacon Newspaper Archive Mukilteo Washington; October Page Topics include mukilteo, city, council, activist, whether, spending,...
Media-Newswire.com - Press Release Distribution - PR Agency
www.media-newswire.com
SEC Charges Seattle-Area Biotech Company With Fraudulently Hyping Stem Cell ... then-Chief Scientific Officer Ronald Berninger of Mukilteo, Wash., originally ...
CellCyte Genetics "strong buy" (FIRSTCLASS INVESTOR) | aktiencheck.de
www.aktiencheck.de
CellCyte Genetics
Former CellCyte Execs Sued by SEC for Role in Pump and Dump Stock ...
www.cbsnews.com
by Trista Morrison In case there's any confusion about why Condé Nast is cutting magazines and staff, Newsweek clears it up : Through August, ad dollars already have plunged by about $600 million from the similar eight-month period in when revenues ...
sortiert nach Relevanz / Datum